ROYAL BANK OF CANADA - SYNTHETIC BIOLOGICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2018$6,000
+50.0%
22,490
+79.3%
0.00%
Q1 2018$4,000
-55.6%
12,544
-34.1%
0.00%
Q4 2017$9,000
-57.1%
19,044
-15.5%
0.00%
Q3 2017$21,000
+75.0%
22,544
+0.2%
0.00%
Q2 2017$12,000
-40.0%
22,490
-25.0%
0.00%
Q1 2017$20,000
-39.4%
29,970
-30.5%
0.00%
Q4 2016$33,000
-55.4%
43,103
+0.0%
0.00%
Q3 2016$74,000
-3.9%
43,0900.0%0.00%
Q2 2016$77,000
+63.8%
43,090
+117.2%
0.00%
Q1 2016$47,000
+38.2%
19,839
+33.7%
0.00%
Q4 2015$34,000
+385.7%
14,839
+436.9%
0.00%
Q3 2015$7,000
-36.4%
2,764
-44.7%
0.00%
Q1 2015$11,0005,0000.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,034,949$1,553,0002.72%
Third Security, LLC 13,238,268$10,095,0000.54%
MSD Partners, L.P. 4,118,402$3,141,0000.16%
SABBY MANAGEMENT, LLC 3,031,953$2,312,0000.13%
Alyeska Investment Group, L.P. 10,000,000$7,626,0000.06%
BARD ASSOCIATES INC 87,999$67,0000.03%
Alyeska Investment Group, L.P. 4,586,592$3,498,0000.03%
FRANKLIN STREET ADVISORS INC /NC 126,000$96,0000.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,000,000$763,000,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$18,0000.01%
View complete list of SYNTHETIC BIOLOGICS INC shareholders